Urinary metabolites of a novel quinoxaline non-nucleoside reverse transcriptase inhibitor in rabbit, mouse and human: identification of fluorine NIH shift metabolites using NMR and tandem MS

By Dear G. J.   Ismail I. M.   Mutch P. J.   Plumb R. S.   Davies L. H.   Sweatman B. C.  

Xenobiotica, Vol. 30, Iss. 4, 2000-04 ,pp. : 407-426

Informa Healthcare

Access to resources Recommend Favorite

The disposition and metabolism of GW695634: A non-nucleoside reverse transcriptase inhibitor (NNRTi) for treatment of HIV/AIDS

By de Serres Mark   Moss Lee   Sigafoos James   Sefler Andrea   Castellino Stephen   Bowers Gary   Serabjit-Singh Cosette  

Xenobiotica, Vol. 40, Iss. 6, 2010-06 ,pp. : 437-445

Informa Healthcare

Access to resources Recommend Favorite

Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man

By Allan G.   Davis J.   Dickins M.   Gardner I.   Jenkins T.   Jones H.   Webster R.   Westgate H.  

Xenobiotica, Vol. 38, Iss. 6, 2008-06 ,pp. : 620-640

Informa Healthcare

Access to resources Recommend Favorite

Investigation of Novel Lipid-Functionalized PNA Monomers as Potential HIV-1 Non-Nucleoside Reverse Transcriptase and/or Integrase Inhibitors

By Thomas Michael   Maga Giovanni   Mouscadet Jean-François   Howarth Nicola  

Nucleosides, Nucleotides & Nucleic Acids, Vol. 26, Iss. 8-9, 2007-08 ,pp. : 1063-1066

Taylor & Francis Ltd

Access to resources Recommend Favorite

Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase

By D'cruz Osmond J.   Uckun Fatih M.  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 21, Iss. 4, 2006-08 ,pp. : 329-350

Informa Healthcare

Access to resources Recommend Favorite